161 related articles for article (PubMed ID: 38235319)
21. Role of activin A in the induction of Foxp3+ and Foxp3- CD4+ regulatory T cells.
Huber S; Schramm C
Crit Rev Immunol; 2011; 31(1):53-60. PubMed ID: 21395511
[TBL] [Abstract][Full Text] [Related]
22. Natural and inducible Tregs in swine: Helios expression and functional properties.
Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
[TBL] [Abstract][Full Text] [Related]
24. Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.
Prochazkova J; Fric J; Pokorna K; Neuwirth A; Krulova M; Zajicova A; Holan V
Immunology; 2009 Sep; 128(1 Suppl):e670-8. PubMed ID: 19740328
[TBL] [Abstract][Full Text] [Related]
25. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
26. Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.
Han Y; Yang Y; Chen Z; Jiang Z; Gu Y; Liu Y; Xu S; Lin C; Pan Z; Zhou W; Cao X
J Mol Med (Berl); 2014 May; 92(5):539-50. PubMed ID: 24668348
[TBL] [Abstract][Full Text] [Related]
27. A dynamic dual role of IL-2 signaling in the two-step differentiation process of adaptive regulatory T cells.
Guo Z; Khattar M; Schroder PM; Miyahara Y; Wang G; He X; Chen W; Stepkowski SM
J Immunol; 2013 Apr; 190(7):3153-62. PubMed ID: 23427250
[TBL] [Abstract][Full Text] [Related]
28. Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function.
Bertolino P; Holmberg R; Reissmann E; Andersson O; Berggren PO; Ibáñez CF
Proc Natl Acad Sci U S A; 2008 May; 105(20):7246-51. PubMed ID: 18480258
[TBL] [Abstract][Full Text] [Related]
29. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
[TBL] [Abstract][Full Text] [Related]
30. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.
Moo-Young TA; Larson JW; Belt BA; Tan MC; Hawkins WG; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunother; 2009 Jan; 32(1):12-21. PubMed ID: 19307989
[TBL] [Abstract][Full Text] [Related]
31. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
Beauford SS; Kumari A; Garnett-Benson C
BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
[TBL] [Abstract][Full Text] [Related]
32. Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β.
Schmidt A; Zhang XM; Joshi RN; Iqbal S; Wahlund C; Gabrielsson S; Harris RA; Tegnér J
Immunol Cell Biol; 2016 Sep; 94(8):747-62. PubMed ID: 27075967
[TBL] [Abstract][Full Text] [Related]
33. ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.
Michael IP; Saghafinia S; Tichet M; Zangger N; Marinoni I; Perren A; Hanahan D
Dev Cell; 2019 May; 49(3):409-424.e6. PubMed ID: 31063757
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
[TBL] [Abstract][Full Text] [Related]
35. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.
Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K
Front Immunol; 2018; 9():125. PubMed ID: 29456534
[TBL] [Abstract][Full Text] [Related]
36. Rubiginosin B selectively inhibits Treg cell differentiation and enhances anti-tumor immune responses by targeting calcineurin-NFAT signaling pathway.
Geng CA; Chen FY; Zheng JB; Liao P; Li TZ; Zhang XM; Chen X; Chen JJ
Phytomedicine; 2023 Jul; 116():154898. PubMed ID: 37247590
[TBL] [Abstract][Full Text] [Related]
37. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
39. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.
O'Connor RA; Leech MD; Suffner J; Hämmerling GJ; Anderton SM
J Immunol; 2010 Dec; 185(12):7235-43. PubMed ID: 21084662
[TBL] [Abstract][Full Text] [Related]
40. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
